Key facts
- VB Tech.’s last known valuation is $42.8M (Jan 2026).
- It has raised $6.2M; the latest was Early Stage VC ($5.9M) in Jan 2026.
- Notable investors include Marseille Innovation.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for VB Tech.
- ·The full record, as it builds
Funding rounds
No funding rounds for VB Tech. are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VB Tech.
Developer of a digital brain twin platform intended to enhance precision in neurological therapy. The company's platform generates personalized, whole-brain simulations by integrating multimodal neuroimaging and electrophysiological data, offers interactive browser-based exploration, automated preprocessing, advanced inference modules, virtual testing of resections or neurostimulation protocols through its clinical VEP module, and supports both invasive and non-invasive workflows, providing clinicians and neuroscience researchers with data-driven predictive insights to optimize diagnosis, treatment planning, and improve outcomes for patients facing complex brain disorders.
- Sector
- Healthcare
- HQ
- Aix-en-Provence, France
- Founded
- 2021
- Employees
- 4
- Website
- virtualbraintech.com/
- Ownership
- Privately Held (backing)
VB Tech. doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VB Tech. shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VB Tech. in its N-PORT filings yet. We sweep new filings monthly.